New Targeting and Delivery Approaches
De som köpt den här boken har ofta också köpt Bad Therapy av Abigail Shrier (inbunden).
Köp båda 2 för 2498 krMara Jos Alonso is Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC) in Spain. She has made critical contributions to the design of novel nanostructures for the targeted delivery of drugs and vaccines and to the understanding of the interaction of nanoparticles with biological barriers. She is part of the scientific boards of a number of societies and the executive board of the Controlled Release Society. She is also a member of the editorial board of eight prestigious journals in the field of drug delivery. Marcos Garcia-Fuentes is an Associate Professor of Pharmacy at Spains University of Santiago de Compostela (USC), where he also obtained his Ph.D. He was a visiting scholar at Purdue University in Indiana, USA and a Marie Curie postdoctoral scientist at ETH Zurich in Switzerland. He was recognized with a competitive contract from the regional government for the reintegration of excellent researchers. Marcos has work in the design of biomaterials and nanostructures for medical applications. His current focus is on nanomedicines and biomaterials for modulating progenitor cells and cancer stem cells.
1 Passive vs active targeting: an update of the EPR role in drug delivery to tumors.- 2 The EX and the SOMA: How they communicate.- 3 Polymeric nano carriers for cancer therapy .- 4 Targeted Liposomes and Micelles as Carriers for Cancer Therapy.- 5 Photodynamic therapy for cancer: principles, clinical applications and nano technological approaches.- 6 Cancer Vaccines: fundamentals and strategies.- 7 Cancer immune modulation and immunosuppressive cells: current and future therapeutic approaches.- 8 Nanotechnology and cncer immunomodulation.- 9 RNAi-based Nano-Oncologicals Delivery and Clinical Applications.- 10 Nano-Platforms for Tumor-Targeted Delivery of Nucleic Acid Therapies.- 11 Multifunctional Gold Nano carriers for Cancer Theranostics From bench to bedside and back again?.- 12 Micro bubbles as Theranostics Agents.- 13 Multimodal Nano-Systems for Cancer Diagnosis, Imaging and Therapy.- 14 Nano toxicology: Towards Safety-by-Design.- 15 Regulatory aspects of oncologicals: nano systems main challenges.- 16 BO-110, a dsRNA-based anticancer treatment.